A detailed history of Aviva PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Aviva PLC holds 14,123 shares of RPRX stock, worth $342,906. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,123
Previous 14,171 0.34%
Holding current value
$342,906
Previous $373,000 6.97%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$25.63 - $29.27 $1,230 - $1,404
-48 Reduced 0.34%
14,123 $399,000
Q1 2024

May 14, 2024

BUY
$27.46 - $31.33 $4,860 - $5,545
177 Added 1.26%
14,171 $430,000
Q3 2023

Nov 13, 2023

SELL
$26.26 - $31.38 $1,391 - $1,663
-53 Reduced 0.38%
13,994 $379,000
Q2 2023

Aug 10, 2023

SELL
$29.6 - $36.56 $147,496 - $182,178
-4,983 Reduced 26.18%
14,047 $431,000
Q1 2023

May 12, 2023

SELL
$32.77 - $39.4 $1.01 Million - $1.22 Million
-30,939 Reduced 61.92%
19,030 $685,000
Q4 2022

Feb 09, 2023

SELL
$39.17 - $44.04 $41,050 - $46,153
-1,048 Reduced 2.05%
49,969 $1.98 Million
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $961,466 - $1.08 Million
-24,109 Reduced 32.09%
51,017 $2.05 Million
Q2 2022

Aug 04, 2022

SELL
$37.53 - $44.22 $308,609 - $363,621
-8,223 Reduced 9.87%
75,126 $3.16 Million
Q1 2022

May 13, 2022

BUY
$37.46 - $42.44 $1.23 Million - $1.4 Million
32,894 Added 65.19%
83,349 $3.25 Million
Q4 2021

Feb 10, 2022

SELL
$35.17 - $42.48 $174,161 - $210,360
-4,952 Reduced 8.94%
50,455 $2.01 Million
Q3 2021

Nov 12, 2021

SELL
$36.14 - $42.24 $1.75 Million - $2.05 Million
-48,472 Reduced 46.66%
55,407 $2 Million
Q2 2021

Aug 10, 2021

BUY
$39.85 - $46.63 $62,166 - $72,742
1,560 Added 1.52%
103,879 $4.26 Million
Q1 2021

May 13, 2021

BUY
$42.34 - $52.82 $2.9 Million - $3.62 Million
68,469 Added 202.27%
102,319 $4.46 Million
Q4 2020

Feb 10, 2021

BUY
$36.12 - $50.05 $1.22 Million - $1.69 Million
33,850 New
33,850 $1.69 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.